… Immunotherapy has shown long time remission in a subset of metastatic CRC patients. The
molecular mechanism and emerging roles of immunotherapy in colorectal cancer … are going …

… at overcoming tumor resistance in current immunotherapy approaches are underway. A better
… In this review, we summarize the most recent advances in immunotherapy based on the …

… colorectal cancer has been observed to have a prolonged benefit to immune checkpoint
inhibitors. As a result, pembrolizumab and … on immunotherapy in the colorectal cancer setting, …

… We will then summarize data that might support the development of ICI in localized colorectal
cancer … In this review, we will focus on the key issues at stake in the development of ICI for …

… we discuss the preclinical and clinical development of immunotherapy for treatment of colorectal
cancer … We also consider open questions including optimal combination treatments and …

… Immune checkpoint inhibitors are a class of immunotherapy … the efficacy and timing of
immunotherapy for other subsets of … we aim to examine the three main classes of immunotherapy …

… different immunotherapy approaches [13]. In this review, we evaluate recent immunotherapy
… We summarize data that identifies likely reasons for the low success rates and how these …

… Immunotherapy of Cancer, assessed the Immunoscore assay in 2681 patients with TNM stage
I–III colon cancer (… and centers (r = 0·97 for colon tumor; r = 0.97 for invasive margin; p < 0·…

… Despite the overall excellent tolerability, anecdotally one case of pneumonitis was
reported related to pembrolizumab and we found one case report in the literature of a severe …

… Unfortunately, colorectal cancer (CRC) has so far been mostly refractory to … In this review,
we give an immuno-oncological overview for this disease and describe immunotherapeutic …